The FDA has shown a willingness to approve black box AI diagnostics, citing the approval of Artera AI's pathology model for predicting response to androgen deprivation therapy in prostate cancer, even though its mechanism is not understood.

Noetic AI uses a large language model-based platform to scrape the semantic web and annotate investigational drugs to create a ranked list for its therapeutics team.

Avi Mahajan believes the primary bottleneck in drug development is not the lack of good preclinical assets, but rather determining how well these assets work in patients.